PharmEasy will be acquiring a 66.1% stake in diagnostics services chain Thyrocare for ₹4,546 crore. As part of the transaction, Thyrocare Founder Dr A Velumani will also be investing close to ₹1,500 crore in PharmEasy parent API Holdings for about a 5% stake, filings showed. The deal reportedly marks the first-ever acquisition of a listed company by an Indian unicorn.